Evaluation of a Postcoital Sponge on Self-Reported Vaginal Health Parameters

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorAtlantic Health System

About this trial

LiviWell has developed a product designed for postcoital semen absorption. Previous studies have demonstrated the product rapidly absorbs semen, and leads to less symptoms of postcoital vaginal microbiome disruption such as vaginal odor and discharge. This study will investigate the study device, Livi, in a broader clinical setting.

Eligibility criteria

Qualifiers

Over 18 (for pH subset, 18-45)

Sexually-active with biological men

Willing and able to use product

Resides in continental USA

Disqualifiers

Currently Pregnant or are trying to conceive

Unable to use device due to poor motor function

Unable to sign informed consent

Trial design

Treatments tested in this trial

  • LiviWell Postcoital Vaginal Insert

Treatment groups

1,000 Participants
are divided into 2 treatment groups

Sponsors and collaborators